ETFs Holding AKBA »    AKBA Historical Stock Prices »
AKBA News Video: Mon, Feb 1, 2016, 2:50 PM — Monday's ETF with Unusual Volume: PTH

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Akebia Therapeutics is a biopharmaceutical company focused on developing and delivering therapeutics for patients based on hypoxia-inducible factor biology, and building its pipeline while using its development and commercial capability in renal disease. Co.'s primary product candidate, vadadustat, is an oral therapy in Phase 3 development for the treatment of anemia due to chronic kidney disease. Co.'s portfolio includes product candidates developed internally as well as in-licensed product candidates, such as AKB-5169, which is a differentiated preclinical compound in development as an oral treatment for inflammatory bowel disease. Self directed investors in Akebia Therapeutics Inc will be interested in keeping up with all Akebia Therapeutics Inc news they can find, both AKBA news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on AKBA. At RediNews, we simplify this task by presenting both AKBA news releases originating from Akebia Therapeutics Inc itself, and AKBA news from a variety of media outlets. Visitors can browse this news online and through our AKBA RSS news feed.


AKBA News — Articles, Videos, & Press Releases

First Week of January 2020 Options Trading For Akebia Therapeutics (AKBA)
Tuesday, May 21, 2019, 11:02 AM — Stock Options Channel
Oversold Conditions For Akebia Therapeutics
Tuesday, April 30, 2019, 4:24 PM — Dividend Channel
First Week of AKBA June 21st Options Trading
Monday, April 29, 2019, 10:58 AM — Stock Options Channel
Analysts Anticipate IBB To Hit $141
Thursday, April 25, 2019, 8:10 AM — ETF Channel
Notable Friday Option Activity: AKBA, AMWD, SAM
Friday, April 5, 2019, 3:16 PM — Stock Options Channel
Peek Under The Hood: XBI Has 52% Upside
Thursday, February 21, 2019, 9:29 AM — ETF Channel
Akebia Therapeutics Becomes Oversold (AKBA)
Monday, January 28, 2019, 4:37 PM — Dividend Channel
Short Interest Moves 61% Lower For AKBA
Friday, January 11, 2019, 12:16 PM — Market News Video
Akebia Therapeutics Stock Sees Short Interest Make 334% Move
Thursday, December 27, 2018, 3:45 PM — Market News Video
Akebia Therapeutics Enters Oversold Territory (AKBA)
Friday, December 21, 2018, 12:03 PM — Dividend Channel
Surprising Analyst 12-Month Target For XBI
Tuesday, December 18, 2018, 9:37 AM — ETF Channel
Bullish Two Hundred Day Moving Average Cross - AKBA
Thursday, December 13, 2018, 11:45 AM — Market News Video
Short Interest Falls 24.3% For AKBA
Wednesday, November 28, 2018, 4:13 PM — Market News Video
XBI's Holdings Imply 80% Gain Potential
Thursday, November 15, 2018, 7:32 AM — ETF Channel
How The Parts Add Up: PBSM Targets $33
Monday, October 15, 2018, 7:44 AM — ETF Channel
Analysts Expect IBB Will Reach $145
Friday, September 14, 2018, 7:57 AM — ETF Channel
RSI Alert: Akebia Therapeutics Now Oversold
Monday, September 10, 2018, 4:25 PM — Dividend Channel
Commit To Purchase Akebia Therapeutics At $7.50, Earn 13.9% Annualized Using Options
Tuesday, August 14, 2018, 11:59 AM — Stock Options Channel
Implied IBB Analyst Target Price: $144
Tuesday, August 14, 2018, 7:22 AM — ETF Channel
Akebia Therapeutics Becomes Oversold (AKBA)
Thursday, August 9, 2018, 11:59 AM — Dividend Channel
XBI's Underlying Holdings Imply 37% Gain Potential
Tuesday, July 10, 2018, 7:28 AM — ETF Channel
Akebia Therapeutics Becomes Oversold (AKBA)
Thursday, June 28, 2018, 12:16 PM — Dividend Channel
Investors Snatch AKBA Even Cheaper Than Its Secondary Stock Offering
Wednesday, June 27, 2018, 4:16 PM — Dividend Channel
How The Parts Add Up: XBI Headed For $130
Friday, June 8, 2018, 7:54 AM — ETF Channel
Notable Thursday Option Activity: AKBA, WGO, MU
Thursday, May 31, 2018, 3:21 PM — Stock Options Channel
AKBA is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

VTL News
APT News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

AKBA News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.